STOCK TITAN

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Intra-Cellular Therapies, Inc. will host a conference call and live webcast discussion to provide a corporate update and discuss financial results for the quarter and year ended December 31, 2023. The event will take place on Thursday, February 22, 2024, at 8:30 a.m. Eastern Time. Participants can register for the conference call via a provided link and access the webcast on the Company's website. The focus of the call will be on the development and commercialization of therapeutics for central nervous system disorders.
Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, February 22, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter and year ended December 31, 2023.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006


The event will take place on Thursday, February 22, 2024, at 8:30 a.m. Eastern Time.

The focus will be on providing a corporate update and discussing the details of the Company's financial results for the quarter and year ended December 31, 2023.

Participants can use the provided registration link to complete the online registration process in advance of the conference call.

The webcast can be accessed under 'Events & Presentations' in the Investor Relations section of the Company's website at www.intracellulartherapies.com.

Participants should log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
Intra-Cellular Therapies Inc

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
US
New York

About ITCI

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.